Maple Leaf Research

Maple Leaf Research is a leading clinical research center located in Toronto, Canada, specializing in the study and treatment of infectious diseases. As the research division of the Maple Leaf Medical Group, it focuses primarily on HIV/AIDS, viral hepatitis, and emerging viral threats like COVID-19 and Mpox. The organization has a long-standing reputation for excellence in conducting Phase I through IV clinical trials, contributing significantly to the advancement of antiretroviral and antiviral therapies. By bridging the gap between clinical care and innovative research, Maple Leaf Research provides patients with access to novel treatments while supporting global pharmaceutical development.